Balanced news tone
News Sentiment
SMTI sentiment intelligence
Sanara Medtech Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-4.1% over one week, +14.5% over four weeks, trend active, and below fair value.
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Moderate Buy" from Analysts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 10:42
- Source
- MarketBeat
Enterprise value to revenue forward of Sanara MedTech Inc. – NASDAQ:SMTI
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 10:32
- Source
- TradingView
Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08 - Change of Character
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 02:33
- Source
- dars.gov.et
How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 00:24
- Source
- Stock Traders Daily
Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Sanara MedTech (SMTI) Surges 3.77% as Shares Test Key Resistance - Earnings Miss Risk
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 21 Jun 2026 07:00
- Source
- DonanımHaber
Sanara MedTech (SMTI) Posts Modest Gain as Support Holds Steady - PCR Divergence
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- dars.gov.et
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 16:56
- Source
- Motley Fool
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 23 May 2026 01:14
- Source
- Simply Wall St.
Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI)
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 14 May 2026 07:00
- Source
- Seeking Alpha
Sanara MedTech Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 12:30
- Source
- Moby
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 May 2026 19:02
- Source
- GuruFocus.com
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To Expect
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 13:22
- Source
- GuruFocus.com
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- GlobeNewswire
How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 05 May 2026 13:17
- Source
- Simply Wall St.
What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Nov 2025 08:00
- Source
- simplywall.st
Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Nov 2025 08:00
- Source
- Quiver Quantitative
The recent pullback must have dismayed Sanara MedTech Inc. (NASDAQ:SMTI) insiders who own 31% of the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2025 07:00
- Source
- simplywall.st
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Jul 2022 07:00
- Source
- GlobeNewswire
Sanara MedTech (SMTI) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Oct 2019 14:54
- Source
- MarketBeat